Stocks
Intellia Therapeutics (NTLA) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -29.5 | 2.36 | 1.57 | -1.45 | -1.56 | -3.93 | ||
| Changes by years, y/y, % | +55% | -108% | -33% | -192% | +7% | -39.4% | |||
Intellia Therapeutics. EV/EBITDA
Intellia Therapeutics. EV/EBITDA, changes, %
Intellia Therapeutics (NTLA) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.66 | -1.25 | -3.33 | -1.51 | -3.18 | -3.93 | |
| Changes by years, y/y, % | -149% | -210% | +16% | -1% | +381% | |||
| Changes by quarters, q/q, % | -56% | +89% | +167% | -55% | +111% | |||
